After fixation in the human genome, human endogenous retroviruses (HERVs) are bona fide cellular genes despite their exogenous origin. To be able to spread within the germ line and the early embryo, the ancient retroviral promoters must have adapted to the requirements for expression in these cell types. We describe that in contrast to the case for current exogenous retroviruses, which replicate in specific somatic cells, the long terminal repeat (LTR) of the human endogenous retrovirus HERV-K acts as a TATA-and initiator elementindependent promoter with a variable transcription start site. We present evidence that the HERV-K LTR is regulated by the transcription factors Sp1 and Sp3. Mutating specific GC boxes, which are binding sites for Sp proteins, and knocking down Sp1 and Sp3 by use of small interfering RNA (siRNA) significantly reduced the promoter activity. Binding of Sp1 and Sp3 to the promoter region was confirmed using electrophoretic mobility shift assays (EMSAs) and chromatin immunoprecipitation (ChIP). Our data explain why certain HERV-K proviruses have lost promoter competence. Since vertebrate promoters lacking canonical core promoter elements are common but poorly studied, understanding the HERV-K promoter not only will provide insight into the regulation of endogenous retroviruses but also can serve as a paradigm for understanding the regulation of this class of cellular genes.Human endogenous retroviruses (HERVs) bear witness that during primate/human evolution exogenous retroviruses have repetitively infected and colonized the germ lines of their respective hosts. HERV sequences constitute approximately 8% of the human genome. However, all present-day proviral loci in the human lineage are rendered noninfectious by mutations and deletions, probably through genetic drift and-given the mutagenic potential of retroviruses-selection for replicationincompetent proviruses. In addition, detailed in silico analyses showed that several HERV proviruses are already inactivated during the primary infection cycle by an APOBEC3G cytosine deaminase, an antiretroviral gene which leaves specific mutation marks within the proviral DNA (17, 33).